Simpson Thacher & Bartlett advised Cisco Systems, Inc. on the offering, and Davis Polk & Wardwell advised the representatives of the underwriters. Cisco Systems, Inc. (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised IDEAYA Biosciences, Inc. on the offering, and Davis Polk & Wardwell advised Jefferies LLC, as sales agent. IDEAYA Biosciences, Inc. (NYSE: IDYA)...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised IDEAYA Biosciences, Inc. on the offering, and Davis Polk & Wardwell advised the representatives of the several underwriters. IDEAYA Biosciences, Inc. (NASDAQ:IDYA)...
You must be a Standard 1 Year member to access this content.
Cooley advised RAPT Therapeutics, Inc. and Davis Polk & Wardwell advised the sales agents on the offering. RAPT Therapeutics, Inc. (Nasdaq:RAPT) announced the SEC-registered at-the-market offering of its common...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Recursion Pharmaceuticals, Inc.; and Davis Polk & Wardwell LLP advised Jefferies LLC, as sales agent, in the offering. Recursion Pharmaceuticals,...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP advised IDEAYA Biosciences, Inc., while Davis Polk & Wardwell LLP advised Jefferies LLC in the offering. IDEAYA Biosciences, Inc. announced the SEC-registered at-the-market...
You must be a Standard 1 Year member to access this content.
Cooley advised AN2 Therapeutics on the offering, and Davis Polk advised the sales agent. AN2 Therapeutics, Inc. announced the SEC-registered at-the-market offering of its common stock...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Pacific Biosciences of California on the offering, and Davis Polk advised the representatives of the several underwriters involved. Pacific Biosciences of California Inc. announced...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the placement agents in the transaction. Recursion Pharmaceuticals executed its $150 million private placement of common stock. Morgan Stanley & Co. LLC acted as the...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented IDEAYA, while Davis Polk advised the representatives of the several underwriters in the offering. IDEAYA Biosciences, Inc. (Nasdaq: IDYA) announced the pricing of an...
You must be a Standard 1 Year member to access this content.
Davis Polk advised J.P. Morgan Securities as representative of the initial purchasers on the offering. Carvana Co. announced its debt offering of $3.275 billion aggregate principal amount...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Caravan, while Davis Polk advised the representatives of the several underwriters in the offering. Carvana, Co. executed its offering of 15,625,000 shares of...
You must be a Standard 1 Year member to access this content.
